Optive Fusion combines hyaluronic acid (HA) and carmellose sodium (CMC) with osmoprotectants to deliver fast relief for dry eyes.1,2
The clinically tested ingredients in Optive Fusion coat the ocular surface with a hydrating and lubricating protective layer. HA is naturally found in the eye and acts as an ocular lubricant.3 CMC is a mucoadhesive agent, which lubricates and protects the eye surface, while osmoprotectants, including glycerin, help restore osmotic balance and hydrate the cells on the eye surface.2
Optive Fusion is compatible with contact lenses. A preservative-free formulation is available in addition to a multidose bottle.4
References
1. Australia Medicine Handbook (online), Dry eye. 2022
2. Simmons PA, et al. Clin Ophthalmol. 2015; 9: 665-75.
3. Goa KL, Benfield P. Drugs. 1994;47(3):536-566.
4. Optive Fusion PI 5. Optive Fusion PF PI
© All rights reserved. OPTIVE FUSION and its design are trademarks of Allergan, Inc., an AbbVie company. AbbVie Pty Ltd, Mascot, NSW 2020. ABN 48 156 384 262. AU-OPF-230004. Jul 23.
